NPPA Revises Ceiling Price of Coronary Stents
New Delhi: Through a recent notification, after considering the Wholesale Price Index (WPI) @ 1.74028% for the year 2024 over 2023, the National Pharmaceutical Pricing Authority (NPPA) has revised and fixed the ceiling price of two Coronary Stents, Bare Mental Stents and Drug Eluting Stents (DES) including metallic DES and Bioresorbable Vascular Scaffold (BVS)/ Biodegradable Stents.
According to the new price notified by the drug price regulator, the ceiling price of Bare Mental Stents is Rs 10692.69 & Drug Eluting Stents (DES) including metallic DES and Bioresorbable Vascular Scaffold (BVS)/ Biodegradable Stents is Rs 38933.14.
A bare-metal stent is a stent made of thin, uncoated (bare) metal wire that has been formed into a mesh-like tube. The first stents licensed in cardiac arteries were bare metal – often 316L stainless steel. More recent "second generation" bare-metal stents of cobalt-chromium alloy have been made. While plastic stents were first used to treat gastrointestinal conditions of the esophagus, gastroduodenal, biliary ducts, and colon, bare-metal stent advancements led to their use for these conditions starting in the 1990s.
Drug-eluting stents (DES) are vascular prostheses used by interventional cardiologists to reopen and maintain patent coronary arteries narrowed by arteriosclerosis.
Earlier, the Medical Dialogue Team reported the ceiling price revision of two coronary stents—Bare Metal Stents and Drug Eluting Stents (DES), including metallic DES and Bioresorbable Vascular Scaffold (BVS)/Biodegradable Stents, in consideration of the Wholesale Price Index (WPI) at 0.00551% for the year 2023 over 2022.
The notice stated that in continuation of the notifications issued by National Pharmaceutical Pricing Authority, Department of Pharmaceuticals, Ministry of Chemical and Fertilizers vide S.O. 639(E) dated 12.02.2018, S.O. 1464(E) dated 02.04.2018, S.O. 1488(E) dated 29.03.2019, SO. 1217(E) dated 25.03.2020, S.O. 1334(E) dated 25.03.2021, 1502(E) dated 30.03.2022, 5249(E) dated 11.11.2022, 1572(E) dated 31.03.2023, 4663(E) dated 25.10.2023, 1551(E) dated 26.03.2024 and 1605 (E) dated 03.04.2024 regarding the fixation of ceiling price of the Coronary Stents as specified in column no. (2) mentioned in the table below; after considering the Wholesale Price Index (WPI) @ 1.74028% for the year 2024 over 2023, it has been decided to revise the ceiling prices of Coronary Stents as mentioned in column no. (4) in the table below, exclusive of Goods and Services Tax as applicable, and unit specified in column (3) with effect from 01.04.2025, as under:
Sl. No | Coronary Stents (Sl. No. 28 in Schedule-I of the DPCO, 2013) | Unit (in Number) | Ceiling price (w.e.f. 1.4.2025 with WPI @1.74028%) (in Rs.) |
(1) | (2) | (3) | (4) |
1 | Bare Metal Stents | 1 | 10692.69 |
2 | Drug Eluting Stents (DES) including metallic DES and Bioresorbable Vascular Scaffold (BVS)/ Biodegradable Stents | 1 | 38933.14 |
The notification further added:
- All the existing manufacturers/importers of Coronary Stents having MRP lower than the ceiling price specified in column (4) in the above table (plus Goods and Services Taxes as applicable, if any), may revise the existing MRP of Coronary Stent, on the basis of WPI @ 1.74028% for the year 2024 over 2023 in accordance with Paragraph 16(2) of DPCO, 2013, read with Para 13(2) of DPCO, 2013.
- The manufacturers/importers of Coronary Stents may add Goods and Services Taxes only if they have paid actually or if it is payable to the Government on the ceiling price mentioned in column (4) of the aforesaid table.
- As per Para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer/importers, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.
- The manufacturers not complying with the ceiling price and notes specified hereinabove shall be liable to deposit the overcharged amount along with interest thereon under the provisions of the Drugs (Prices Control) Order, 2013 read with Essential Commodities Act, 1955.
To view the official notice, click the link below:
